Catherine Verhaeghe

Catherine Verhaeghe holds a PhD in Molecular Biology from the University of Liege (Belgium). Catherine began her career at David Erle Lab at UCSF (USA), where she identified new molecules involved in goblet cell hyperplasia in lung and intestinal diseases. With her extensive expertise in project and team management, in vivo mouse models, inflammation, signaling pathways, and oncology, she has made significant contributions in respiratory diseases (Cystic fibrosisis, asthma). As the COO, Catherine’s mission is to ensure the highest quality service for TransCure bioServices’ clients and to optimize the company’s processes. Through dedication to excellence and deep scientific and operational experience, Catherine now leads the company’s growing operations towards success.